Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers review the similarities and differences between OARSI and ESCEO 2019 guidelines for the management of knee osteoarthritis (OA) and provide a narrative to help steer health-care providers through the complexities of non-surgical management of the disease.

A doctor treats a patient with knee osteoarthritis

The burden of knee osteoarthritis is set to continue to increase around the world. Ageing populations and rising levels of obesity, combined with an absence of a cure for the disease, will lead to an increased strain on health-care systems. Due to this, there is a focus on how to best manage the disease.  

Clinical management is difficult and recommended treatment strategies routinely include a combination of non-pharmacological, pharmacological and in some cases surgical interventions. Management can further be categorised by disease severity, joint site and the presence/absence of comorbidities making OA treatment increasingly personalised.

Read the full news item on the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences website